| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 10/26/2006 | CA2604515A1 Toll-like receptor 14 (tlr14 ) and use thereof |
| 10/26/2006 | CA2604222A1 Il-21 variants |
| 10/26/2006 | CA2603794A1 Syphilis diagnostic test and kits |
| 10/26/2006 | CA2602635A1 Method of altering the binding specificity of proteins by oxidation-reduction reactions |
| 10/26/2006 | CA2599525A1 Hiv vif mutants |
| 10/26/2006 | CA2598146A1 Cxcr3 is a gliadin receptor |
| 10/25/2006 | EP1715064A1 Nucleotide sequences derived from the genomes of the retroviruses HIV-1, HIV-2 and SIV, and their application to the amplification of these viral genomes and to the in vitro diagnosis of infections resulting from these viruses |
| 10/25/2006 | EP1715055A2 Process for the production of L-amino acids using improved Enterobacteriaceae strains |
| 10/25/2006 | EP1715050A1 Paraquat resistance gene and a vascular tissue- and trichome-specific promoter |
| 10/25/2006 | EP1715047A2 Recombinant mutants for inducing specific immune responses |
| 10/25/2006 | EP1715046A2 New polypeptide, DNA encoding the polypeptide, recombinant vector bearing the DNA and recombinant virus utilizing the recombinant vector as well as use thereof |
| 10/25/2006 | EP1715045A2 Recombinant antibodies for human therapy |
| 10/25/2006 | EP1715044A2 Human neurexin-like proteins and polynucleotides encoding the same |
| 10/25/2006 | EP1715043A2 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use |
| 10/25/2006 | EP1715042A1 EPITOPE/PEPTIDE RECOGNIZED BY HLA-A2402-RESTRCITED Ep-CAM-SPECIFIC CTL AND USE OF THE SAME |
| 10/25/2006 | EP1715040A2 Zinc finger binding domains for GNN |
| 10/25/2006 | EP1714982A2 Methods for purifying highly anionic proteins |
| 10/25/2006 | EP1714981A2 Method for the identification of antigenic peptides |
| 10/25/2006 | EP1714980A1 Human receptor proteins, related reagents and methods |
| 10/25/2006 | EP1714979A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 10/25/2006 | EP1714978A1 Peptides useful for diagnosis and therapy of tumors |
| 10/25/2006 | EP1714976A1 Amino acid sequences from active principle of musk and their acetic salt, also the preparation and usage |
| 10/25/2006 | EP1714975A2 Gene and peptide for transcriptional repressor |
| 10/25/2006 | EP1714974A2 HIV-1-and HIV-2-peptides for inhibition of membranes fusion-associated events, including HIV transmission |
| 10/25/2006 | EP1714972A2 Method for producing a peptide with a pl above 8 or below 5 |
| 10/25/2006 | EP1714971A2 Directed switch-mediated DNA recombination |
| 10/25/2006 | EP1714969A2 Immunostimulatory nucleic acid molecules |
| 10/25/2006 | EP1714661A2 Methods for diagnosing and treating hemostatic disorders by modulating p-selectin activity |
| 10/25/2006 | EP1713933A1 Vesicle used to separate substances from liquid media |
| 10/25/2006 | EP1713917A2 Pneumolysin derivatives |
| 10/25/2006 | EP1713907A2 Hybrid proteins of active-site serine beta-lactamase. |
| 10/25/2006 | EP1713828A2 Enhanced secretion/retention of growth hormone releasing hormone (ghrh) from muscle cells by species-specific signal peptide |
| 10/25/2006 | EP1713827A2 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of cardiac disease |
| 10/25/2006 | EP1713826A2 Polypeptides comprising the pleckstrin homology domain of ect2 and their binding specificities to phosphatidylinositols |
| 10/25/2006 | EP1713825A2 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
| 10/25/2006 | EP1713824A2 Recombinant viruses with heterologous envelope proteins |
| 10/25/2006 | EP1713821A2 Primary central nervous system tumor specific behab isoforms |
| 10/25/2006 | EP1713723A2 Fullerene based amino acids |
| 10/25/2006 | EP1713511A1 Therapeutic agent for treatment of cancer comprising human apolipoprotein (a) kringles lk68 or lk8 genes as effective ingredient, and method for treating cancer using the same |
| 10/25/2006 | EP1713494A2 Treatment of conditions involving dopaminergic neuronal degeneration using nogo receptor antagonists |
| 10/25/2006 | EP1713493A2 Pituitary adenylate cyclase activating peptide (pacap) receptor (vpac2) agonists and their pharmacological methods of use |
| 10/25/2006 | EP1713441A2 Interleukin-13 antagonist powders, spray-dried particles, and methods |
| 10/25/2006 | EP1713440A2 Engineered proteins, and methods of making and using |
| 10/25/2006 | EP1713325A2 Gene disruptions, compositions and methods relating thereto |
| 10/25/2006 | EP1606628B1 Ph-dependent polypeptide aggregation and its use |
| 10/25/2006 | EP1578967A4 Fluorescent proteins from aquatic species |
| 10/25/2006 | EP1543018A4 Gene families associated with liver cancer |
| 10/25/2006 | EP1532178A4 Artificial transcription factors |
| 10/25/2006 | EP1507869A4 Improved receptor detection |
| 10/25/2006 | EP1501925A4 Identification of a phage associated lytic enzyme to rapidly and specifically detect and kill bacillus anthracis |
| 10/25/2006 | EP1423417B1 Antibodies recognizing a peptide mimicking a cryptic epitope of gp41 of hiv-1 |
| 10/25/2006 | EP1409525B1 Human papillomavirus e2 transactivation domain/inhibitor co-crystal and x-ray coordinates defining the inhibitor-binding pocket |
| 10/25/2006 | EP1377275B1 Vaccine for modulating between t1 and t2 immune responses |
| 10/25/2006 | EP1373308B1 Antagonist for multimerization of hiv-1 vif protein |
| 10/25/2006 | EP1332155B1 Immunization of dairy cattle with gapc protein against streptococcus infection |
| 10/25/2006 | EP1292615B1 Modified morbillivirus v proteins |
| 10/25/2006 | EP1235805B1 Immunoassay for neonicotinyl insecticides |
| 10/25/2006 | EP1194537B1 Mutated nurr1 gene |
| 10/25/2006 | EP1129112B1 Peptides containing a cholesterol recognition sequence and their uses |
| 10/25/2006 | EP1109901B1 GABA B RECEPTOR SUBTYPES GABA B-R1c AND GABA B-R2 AND HETERODIMERS THEREOF |
| 10/25/2006 | EP1104488B1 Linking gene sequence to gene function by three dimensional (3d) protein structure determination |
| 10/25/2006 | EP1097167B1 Neurotrophic growth factor |
| 10/25/2006 | EP1095054B1 Method of using an improved peptide nucleic acid universal library to optimize dna sequence hybridation |
| 10/25/2006 | EP1012286B1 Allelic variant of human stat3 |
| 10/25/2006 | EP0973802B1 Synthetic peptides useful in biological assays for detecting infections caused by group o hiv-1 viruses |
| 10/25/2006 | EP0957902B1 System for genetically treating cardiac conduction disturbances |
| 10/25/2006 | EP0828849B1 High-affinity oligonucleotide ligands to pdgf |
| 10/25/2006 | EP0719339B1 Subtilisin bpn' variants with decreased adsorption and increased hydrolysis |
| 10/25/2006 | CN1852985A Process for the production of fine chemicals |
| 10/25/2006 | CN1852980A Recombinant polypeptide useful for neurotrophin receptor mediated gene delivery and as neurotrophin agonist |
| 10/25/2006 | CN1852977A Expression of dominant negative transmembrane receptors in the milk of transgenic animals |
| 10/25/2006 | CN1852921A Soluble fragments of the SARS-cov spike glycoprotein |
| 10/25/2006 | CN1852919A Agonist polypeptide of receptor for ZOT and zonulin |
| 10/25/2006 | CN1852742A Somatostatin analogs with inhibitory activity to growth hormone release |
| 10/25/2006 | CN1852741A Compounds and methods for downregulating the effects of TGF-beta |
| 10/25/2006 | CN1852736A Immunoglobulin chimeric monomer-dimer hybrids |
| 10/25/2006 | CN1852733A Multivalent meningococcal derivatized polysaccharide-protein conjugates and vaccine |
| 10/25/2006 | CN1852731A Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs |
| 10/25/2006 | CN1852728A Host defense factor X (HDFX) |
| 10/25/2006 | CN1850977A Soluble colibacillus expression plasmid and its use |
| 10/25/2006 | CN1850975A Northeast wild soybean coding DREB transcription factor gene and its cloning method |
| 10/25/2006 | CN1850859A Angiogenin mutant as agonist, and its preparing method |
| 10/25/2006 | CN1850858A Method for purifying mouse herve growth factor for scale-production |
| 10/25/2006 | CN1850857A Rana grahami propyl sperm peptide, gene and variant and its pharmaceutical use |
| 10/25/2006 | CN1850856A Plant anti-reverse related protein, and its coding gene and use |
| 10/25/2006 | CN1850855A Method and composition for immuning or preparing monoclonal antibody |
| 10/25/2006 | CN1850278A Polyethyleneglyol modified recombinant human B lymphocyte stimulating factor and its preparing method |
| 10/25/2006 | CN1281759C Transgenic plant products comprising human granulocyte colony-stimulating factor and method for preparing the same |
| 10/25/2006 | CN1281754C Cold resisting application of glycan aldehydic acid enzyme arrestin gene AtPGIP1 of Arabidopsis thalianum |
| 10/25/2006 | CN1281751C DNA mark for inspecting purity of seeds and method thereof |
| 10/25/2006 | CN1281749C Polypeptides, use thereof and process for producing the same |
| 10/25/2006 | CN1281748C Gene of IL-12 p40 subunit mutated for improving activity of IL-12 and use thereof for DNA vaccine adjuvant |
| 10/25/2006 | CN1281747C i(Ehrlichia canis) 120-KDa immunodominant antigenic protein and gene |
| 10/25/2006 | CN1281626C Method and reagent kit for detecting and measuring 3,4-methylene methedrine (MDMA) |
| 10/25/2006 | CN1281625C WT1 modified peptide |
| 10/25/2006 | CN1281624C Thrombin derivatives and its process for production |
| 10/25/2006 | CN1281623C Human alpha interferon derivative with superstrong antiviral activity |
| 10/25/2006 | CN1281622C Excreted proteins as indicators related to tumor and application |
| 10/25/2006 | CN1281621C Method of diagnosing and treating heritage spasm paraplegia using NIPAl gene mutation hot point |
| 10/25/2006 | CN1281620C Transfection competent molecules |